A study for a 29 year old woman who takes Plavix, Innohep, Citalopram Hydrobromide - from FDA reports

8 females aged 29 (±5) who take the same drugs are studied. This is a personalized study for a 29 year old female patient who has Polycythemia Vera, Depression. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.

On Jan, 17, 2019

8 females aged 29 (±5) who take Plavix, Innohep, Citalopram Hydrobromide are studied.

Number of reports submitted per year:

Plavix, Innohep, Citalopram Hydrobromide for a 29-year old woman.

Information of the patient in this study:

  • Age: 29
  • Gender: female
  • Conditions: Polycythemia Vera, Depression
  • Drugs taken:
    • Plavix (clopidogrel bisulfate)
    • Innohep (tinzaparin sodium)
    • Citalopram Hydrobromide (citalopram hydrobromide)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
1 - 6 months:
6 - 12 months:
1 - 2 years:
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  1. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen)
  2. Pain
  3. Visual field defect
  4. Laboratory test abnormal
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death)
  7. Muscle tightness
  8. Oedema peripheral (superficial swelling)
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. General physical health deterioration (weak health status)

Top conditions involved for these people *:

  1. Birth Control : 2 people, 25.00%
  2. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 12.50%
  3. Stable Angina (a constant chest pain): 1 person, 12.50%
  4. Anaemia (lack of blood): 1 person, 12.50%
  5. Anticoagulant Therapy : 1 person, 12.50%
  6. Arteriogram : 1 person, 12.50%
  7. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 1 person, 12.50%
  8. Diabetes : 1 person, 12.50%
  9. Fistula (an abnormal connection or passageway between two): 1 person, 12.50%
  10. Infection : 1 person, 12.50%

Top co-used drugs for these people *:

  1. Lisinopril (2 people, 25.00%)
  2. Flexeril (2 people, 25.00%)
  3. Ambien (2 people, 25.00%)
  4. Yaz (2 people, 25.00%)
  5. Prilosec (2 people, 25.00%)
  6. Seroquel (2 people, 25.00%)
  7. Fosrenol (1 person, 12.50%)
  8. Fioricet (1 person, 12.50%)
  9. Flovent (1 person, 12.50%)
  10. Folic Acid (1 person, 12.50%)

* Some reports may have incomplete information.

You are not alone:

What are the drugs?

What are the conditions?

Related studies:

FDA reports used in this study

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.